Literature DB >> 2053782

Monitoring TSH concentrations during treatment for congenital hypothyroidism.

D B Grant1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2053782      PMCID： PMC1793167          DOI： 10.1136/adc.66.6.669

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  11 in total

Review 1.  Clinical review 12: The use and misuse of the sensitive thyrotropin assays.

Authors:  J T Nicoloff; C A Spencer
Journal:  J Clin Endocrinol Metab       Date:  1990-09       Impact factor: 5.958

2.  Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma.

Authors:  S Reichlin; R D Utiger
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

3.  Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis.

Authors:  A D Toft; W J Irvine; W M Hunter; J G Ratcliffe; J Seth
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

4.  Elevated threshold for thyrotropin suppression in congenital hypothyroidism.

Authors:  R M Schultz; M S Glassman; M H MacGillivray
Journal:  Am J Dis Child       Date:  1980-01

5.  Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism.

Authors:  J A Germak; T P Foley
Journal:  J Pediatr       Date:  1990-08       Impact factor: 4.406

6.  Reassessment of the daily dose of oral thyroxine for replacement therapy in hypothyroid children.

Authors:  I Rezvani; A M DiGeorge
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

7.  Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism.

Authors:  T Sato; Y Suzuki; T Taketani; K Ishiguro; H Nakajima
Journal:  J Clin Endocrinol Metab       Date:  1977-03       Impact factor: 5.958

8.  Management of patients with congenital hypothyroidism.

Authors:  G J Frost; J M Parkin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

9.  Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism.

Authors:  S S Abusrewil; L Tyfield; D C Savage
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

10.  Growth, development, and reassessment of hypothyroid infants diagnosed by screening.

Authors:  J A Hulse; D B Grant; D Jackson; B E Clayton
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15
View more
  6 in total

1.  Optimisation of thyroxine dose in congenital hypothyroidism.

Authors:  P C Hindmarsh
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

2.  Treatment variables as predictors of intellectual outcome in children with congenital hypothyroidism.

Authors:  S Heyerdahl
Journal:  Eur J Pediatr       Date:  1996-05       Impact factor: 3.183

3.  Factors involved in the rate of fall of thyroid stimulating hormone in treated hypothyroidism.

Authors:  J Raza; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

Review 4.  Congenital hypothyroidism.

Authors:  Maynika V Rastogi; Stephen H LaFranchi
Journal:  Orphanet J Rare Dis       Date:  2010-06-10       Impact factor: 4.123

Review 5.  An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

Authors:  Stefano Stagi; Giovanna Municchi; Marta Ferrari; Malgorzata Gabriela Wasniewska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

6.  Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision).

Authors:  Keisuke Nagasaki; Kanshi Minamitani; Makoto Anzo; Masanori Adachi; Tomohiro Ishii; Kazumichi Onigata; Satoshi Kusuda; Shohei Harada; Reiko Horikawa; Masanori Minagawa; Haruo Mizuno; Yuji Yamakami; Masaru Fukushi; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2015-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.